z-logo
open-access-imgOpen Access
KRAS Mutation Status Predicts Responsiveness to Panitumumab
Author(s) -
Rabiya S. Tuma
Publication year - 2007
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000303243.48567.83
Subject(s) - panitumumab , kras , cetuximab , colorectal cancer , medicine , oncology , cancer , epidermal growth factor receptor , erlotinib , family medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here